Inhaled nitric oxide therapy for preterm infants after 7 days of age: a scoping review protocol.

ABSTRACT:

Introduction

Inhaled nitric oxide (iNO) use is recommended for persistent pulmonary hypertension of the newborn in term and late preterm infants. Recently, iNO therapy to prevent bronchopulmonary dysplasia (BPD) or rescue for hypoxic respiratory failure and pulmonary hypertension secondary to BPD has increasingly been used in preterm infants after 7 days of postnatal age (in the postacute phase), despite its off-label use. However, the initiation criteria of iNO therapy for preterm infants in the postacute phase are varied. The aim of this scoping review is to identify the clinical and/or echo findings at the initiation of iNO therapy in preterm infants in the postacute phase.

Methods and analysis

We will search PubMed, Embase and the Japanese database 'Ichushi.' The followi

SUBMITTER: Minamitani Y 

PROVIDER: S-EPMC10882299 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature